Frank Morales is a Boeing Associate Technical Fellow /Technical Lead for Cloud-Interoperability Native Services at Boeing Global Services, Digital Solutions, and Analytics.
In 1989, He received both B. Eng. and M. Eng. degrees in computer engineering and Avionics and Artificial Intelligence with distinctions from the Institute of Civil Aviation Engineers in Kyiv, Ukraine. He then became a 2001 senior member of IEEE. https://news.ieee.ca/2002/jan2002.htm#smupdates
Frank is a devout inventor, author, and speaker. He holds three US patents (7,092,748, 10,467,910, 10,522,045). He has published several technical peer-review papers in prestigious journals such as Nature and authored a book chapter. He was a speaker at the 59th AGIFORS Annual Symposium with the theme entitled "Multi-Agent Systemic Approach to Support Dynamic Airline Operations based on Cloud Computing." His Google Scholar is here: https://scholar.google.com/citations?user=IlTdC5IAAAAJ&hl=en
He received several individual awards for his accomplishments with The Boeing Co. He also earned accreditation from the Massachusetts Institute of Technology (MIT) in the Sloan Executive Program Field Of Study Technology Strategies and Leadership.
He is a highly commended, analytical, and seasoned professional with a broad background in software and systems architecture, system integration, and project management. He possesses hands-on experience in business solutions architecture in the biomedical technology and aerospace industries. Demonstrate top-notch organizational skills in optimizing strategies to bridge the technical and business worlds while integrating technical solutions toward business problem resolutions.
I love the open-source community, and my GitHub repository for Machine/Deep Learning and AI is here:
https://github.com/frank-morales2020/MLxDL
He speaks fluently Spanish, Russian, and English.
FRANK MORALES | Points |
---|---|
Academic | 20 |
Author | 227 |
Influencer | 36 |
Speaker | 3 |
Entrepreneur | 150 |
Total | 436 |
Points based upon Thinkers360 patent-pending algorithm.
Tags: Agentic AI, Generative AI, Predictive Analytics
Tags: Agentic AI, Generative AI, Predictive Analytics
Tags: Agentic AI, Generative AI, Predictive Analytics
Tags: Agentic AI, Generative AI, Predictive Analytics
Tags: Agentic AI, Generative AI, Predictive Analytics
Tags: Agentic AI, Generative AI, Open Source
Tags: Agentic AI, Generative AI, Open Source
Tags: Agentic AI, Generative AI, Predictive Analytics
Tags: Agentic AI, Generative AI, Predictive Analytics
Tags: Agentic AI, Generative AI, Predictive Analytics
Tags: Agentic AI, Generative AI, Predictive Analytics
Tags: Agentic AI, Generative AI, Predictive Analytics
Tags: Agentic AI, Generative AI, Predictive Analytics
Tags: Agentic AI, Generative AI, Open Source
Tags: Agentic AI, Generative AI, Predictive Analytics
Tags: Agentic AI, Generative AI, Predictive Analytics
Tags: Agentic AI, Generative AI, Predictive Analytics
Tags: Agentic AI, Generative AI, Predictive Analytics
Tags: Agentic AI, Generative AI, Predictive Analytics
Tags: Agentic AI, Generative AI, Predictive Analytics
Tags: Agentic AI, Generative AI, Predictive Analytics
Tags: Agentic AI, AI, Generative AI
Tags: Agentic AI, AI, Generative AI
Tags: Agentic AI, AI, Generative AI
Tags: Agentic AI, AI, Generative AI
Tags: Agentic AI, AI, Generative AI
Tags: Agentic AI, AI, Generative AI
Tags: Agentic AI, AI, Generative AI
Credential ID https://www.linkedin.com/in/frank-morales1964/overlay/1635475339334/single-media-viewer/?profileId=A
Tags: Agentic AI, AI, Open Source
Tags: Agentic AI, AI, Generative AI
Tags: AI, Analytics, Predictive Analytics
Tags: Agile, Analytics, Generative AI
Tags: AI, Analytics, Predictive Analytics
Tags: AI, Generative AI, Predictive Analytics
Patent Number 10467910 and United States Patent 10522045
Tags: Agentic AI, Generative AI, Predictive Analytics
Patent Number United States Patent 7092748
Tags: Agentic AI, Generative AI, Predictive Analytics
Tags: Agentic AI, Open Source, Predictive Analytics
Tags: AI, Generative AI, Predictive Analytics
Tags: Agile, Open Source, Predictive Analytics
Tags: Agentic AI, Generative AI, Predictive Analytics
Tags: Agentic AI, AI, Predictive Analytics
The quest for new medicines has historically been a protracted and resource-intensive endeavour, often marked by trial-and-error experimentation and substantial financial investments. However, the advent of artificial intelligence is rapidly transforming this landscape, ushering in an era of 'in silico' drug discovery. This paradigm shift, vividly demonstrated by an ADMET agentic AI pipeline featuring a Grok-4 agent, holds the promise to significantly accelerate the identification of promising drug candidates by simulating complex biological and chemical processes computationally, instilling optimism about the future of pharmaceutical research.
In silico ADMET refers to the use of computational (or "silico") methods to predict the Absorption, Distribution, Metabolism, Excretion, and Toxicity of chemical compounds, particularly drug candidates.
Here's a breakdown:
Purpose in Drug Discovery: The primary goal of in silico ADMET prediction is to screen potential drug candidates early in the discovery process. By predicting these properties computationally, researchers can:
The concept behind the provided code is to demonstrate a simulated in silico drug discovery pipeline using an AI agent. This pipeline leverages a large language model (LLM), specifically a simulated Grok-4 agent, to orchestrate and automate various steps in the drug discovery process. The core idea is to replace or augment traditional, time-consuming, and expensive wet-lab experiments with computational simulations. By using specialized "tools" that mimic real-world drug discovery actions (like synthesizing molecules, identifying disease targets, running assays, and predicting ADMET properties), the AI agent can rapidly explore, evaluate, and prioritize potential drug candidates. The code establishes a framework where the AI agent receives a query, determines which computational tool is most suitable to address that query, executes the tool (which provides simulated results), and then interprets these results to give a coherent response. This enables a fast, iterative, and data-driven approach to drug discovery, allowing researchers to quickly filter out unpromising compounds and focus resources on those with the highest potential. The "simulation" aspect means that while the interactions between the agent and the tools are fundamental, the outcomes of the drug discovery steps (e.g., yield percentage, binding affinity) are randomly generated to illustrate the process, rather than reflecting actual experimental data.
The Grok-4 agent, serving as the intelligent orchestrator of the sophisticated pipeline, is equipped with a suite of specialized tools. This AI acts as a central brain, interpreting complex queries and delegating tasks to the appropriate computational modules. Whether the task involves synthesizing a molecule, identifying a disease target, simulating an assay, or predicting ADMET properties, the agent seamlessly integrates these diverse functionalities, enabling a highly efficient workflow.
The final output presents a simulated drug discovery pipeline managed by a Grok 4 agent, demonstrating its capabilities through a series of seven distinct steps.
While the current demonstration operates in a simulated environment, the implications of such an ADMET agentic AI pipeline are profound. It represents a significant leap towards truly automated and intelligent drug discovery, where AI can not only process vast amounts of data but also make informed decisions, suggest modifications, and predict outcomes with unprecedented speed. This capability holds the potential to drastically accelerate the pace at which new therapeutic agents are brought to market, offering hope for addressing currently intractable diseases. By integrating advanced AI with specialized computational tools, the future of drug discovery promises to be more efficient, cost-effective, and ultimately, more successful in delivering life-changing medicines.
Tags: Agentic AI, Generative AI, Predictive Analytics
The intricate process by which a linear chain of amino acids folds into a unique, three-dimensional structure is fundamental to all biological life. This "protein folding problem" is notoriously complex, yet its understanding is crucial for advancements in medicine, biotechnology, and material science. The advent of artificial intelligence presents powerful new avenues for tackling this challenge. As demonstrated by a recent AI agent system, a modular, multi-agent approach can effectively dissect and address various facets of protein folding, from data acquisition to ethical considerations, showcasing a sophisticated framework for scientific inquiry.
At the heart of this innovative approach lies the multi-agent paradigm. Instead of a monolithic AI attempting to solve the entire problem, the system employs several specialized AI agents, each endowed with distinct expertise and a set of tools. This modularity offers significant advantages: it allows for the division of labour, promotes scalability, and enables each agent to specialize in a specific domain, thereby enhancing efficiency and accuracy. This specialization reflects the collaborative nature of real-world scientific research, where experts from various fields come together to achieve a common goal, inviting you to be part of this collaborative journey.
The practical application of the MISTRAL AI system's conceptual framework is vividly illustrated through the agents' outputs. The Protein Sequence Data Agent, acting as a biological librarian, swiftly fetches an amino acid sequence and associated metadata for a given protein ID, even identifying existing experimental 3D structures. This immediate access to foundational data is a clear demonstration of the system's capabilities.
Following this, the Folding Prediction & Simulation Agent steps in, conceptually simulating the dynamic process of folding. While a short amino acid sequence might prove insufficient for a meaningful prediction, the agent can still outline the process of molecular dynamics simulation, detailing how minor structural fluctuations might occur over a short period, such as 10 nanoseconds. This highlights the agent's understanding of the underlying scientific principles, even when precise data is limited.
The code demonstrates the architecture and functionality of an AI agent system designed for protein folding analysis. The core concept is to use a multi-agent system built with the Mistral AI SDK to simulate a complex scientific workflow. The system is structured around several specialized agents, each responsible for a specific domain task:
Conceptual Simulation: The demonstration utilizes 'mock' functions to simulate the behaviour of complex scientific processes (such as AlphaFold or GROMACS), illustrating how agents would interact in a real-world scenario without requiring actual high-performance computing resources. This showcases the system's ability to handle complex scientific processes, instilling confidence in its capabilities. The overall goal is to showcase how AI agents can be configured and tested to automate a scientific workflow, explicitly addressing the challenges of protein folding and analysis.
The final output of the code, as presented in the provided code, summarizes the results of the executed test cases and the interactions between the agents. The code execution output demonstrates that the AI agents successfully performed their designated tasks using the conceptual (mock) tools defined in the notebook.
Here is a summary of the final output for each test case:
Further along the analytical pipeline, the Misfolding Analysis & Intervention Agent takes center stage. Protein misfolding is implicated in numerous diseases, making its identification paramount. This agent can pinpoint 'hotspots' – specific regions within a protein prone to misfolding or aggregation. By analyzing simulated data, it identifies areas, such as residues 600-610 and 980-990 in a hypothetical protein, attributing their propensity for misfolding to hydrophobic patches. Such insights are invaluable for understanding disease mechanisms and designing therapeutic interventions. Finally, to consolidate these disparate findings, the Result Synthesis & Interpretation Agent weaves together the predicted structures, folding dynamics, and misfolding analyses into a comprehensive report, complete with confidence scores and potential chaperone recommendations. This agent transforms raw data and analytical insights into actionable knowledge, demonstrating the power of AI in generating structured scientific summaries and empowering you with comprehensive information.
Beyond the purely scientific aspects, the system also incorporates a crucial dimension: ethical consideration. The Historical & Ethical Context Agent provides a broader perspective, capable of recalling significant milestones in protein science, such as Cyrus Levinthal's paradox, which underscored the immense complexity of protein folding.
In essence, this multi-agent AI system for protein folding exemplifies a powerful approach to tackling complex scientific problems. By breaking down a grand challenge into manageable, specialized tasks handled by interconnected agents, the system demonstrates how AI can facilitate comprehensive analysis, accelerate discovery, and even integrate ethical foresight into the scientific process. While the current demonstration utilizes conceptual mock data, the underlying framework lays a robust foundation for future AI-driven research, promising to unlock more profound insights into protein behaviour and its implications for human health.
Tags: Agentic AI, Generative AI, Open Source
The landscape of scientific inquiry is rapidly evolving, driven by the increasing complexity of grand challenges that defy traditional, single-disciplinary approaches. From the mysteries of the universe to the intricacies of life at the molecular level, these problems demand innovative solutions. A promising paradigm emerging to meet this demand is the development of modular AI agent frameworks, which leverage diverse large language models (LLMs) and specialized tools to orchestrate sophisticated problem-solving. This approach, exemplified by the MSTRAL AI Agents framework, provides a powerful blueprint for accelerating discovery, sparking curiosity, and inspiring exploration, as demonstrated by its conceptual application to the notoriously challenging protein folding problem.
The code illustrates a conceptual framework for developing and evaluating AI agents intended to address complex scientific challenges. The core idea is to break down a significant, multifaceted problem (like understanding protein folding or proving relativity) into smaller, manageable sub-problems, each handled by a specialized AI agent. Here's the breakdown of the concept:
Based on the code, two different Large Language Models (LLMs) are used for the AI agents, both developed by Mistral AI:
A crucial strategic advantage of this modular design lies in its capacity to incorporate diverse LLMs. The framework enables different agents to be powered by various underlying large language models, each selected for its specific strengths and capabilities. For instance, an agent tasked with broad knowledge retrieval, such as a "Protein Sequence Data Agent," might utilize a powerful model like mistral-large-latest. This model's "large-latest" designation suggests it is optimized for comprehensive understanding and complex reasoning across vast datasets, making it ideal for fetching diverse scientific information. Conversely, agents focused on more analytical, conceptual, or synthesis-oriented tasks, like the "Folding Prediction & Simulation Agent" or the "Result Synthesis & Interpretation Agent," might employ a "medium-latest" model. The magistral-medium-latest model noted as the primary Mistral AI model for these agents in the provided context, is likely selected for its balance of robust analytical capabilities and computational efficiency. This strategic matching of LLM capabilities to agent-specific tasks ensures that each component of the problem-solving pipeline is handled by the most suitable AI, optimizing both performance and resource utilization.
The practical utility of this framework is vividly illustrated by its conceptual application to the protein folding problem in bioscience. This challenge, encapsulated by Levinthal's Paradox, seeks to understand how proteins rapidly achieve their precise three-dimensional structures and, conversely, how misfolding leads to debilitating diseases.
The final output demonstrates the successful execution of refactored AI agents designed to tackle the protein folding problem, leveraging the Mistral AI Agents framework. The agents were successfully created and interacted with their respective mock tools, responding relevant to the bioscience field. Specifically, the output shows:
The "Protein Sequence Data Agent" successfully retrieves mock protein sequences and experimental structure data, laying the groundwork for analysis. The "Folding Prediction & Simulation Agent" conceptually attempts to predict protein structures and simulate molecular dynamics, thereby demonstrating the modelling aspect. The "Misfolding Analysis & Intervention Agent" identifies hypothetical misfolding hotspots and suggests interventions, showcasing its role in disease understanding. All these findings are then consolidated by the "Result Synthesis & Interpretation Agent" into a comprehensive report. Furthermore, the "Historical & Ethical Context Agent" offers a broader perspective, discussing milestones such as Levinthal's Paradox and analyzing the ethical implications of cutting-edge bioscience applications, including CRISPR for proteinopathies. The output demonstrates the agents' ability to process queries, invoke their specialized tools (even if mocked), and generate domain-specific responses, showcasing the framework's potential for tackling real-world scientific complexities.
The implications of such AI agent frameworks for scientific discovery are profound. By automating and intelligently orchestrating complex research workflows, these systems can accelerate hypothesis generation, data analysis, and experimental design. They offer the capacity to navigate and synthesize vast amounts of information, identify subtle patterns that human researchers might miss, and explore computational spaces far more efficiently. This represents a significant step beyond simple automation, moving towards a future where AI agents act as intelligent, collaborative partners in the scientific process, freeing human researchers to focus on higher-level conceptualization and interpretation. The modularity and adaptability of this framework suggest that its applicability extends beyond bioscience to other grand challenges, including drug discovery, materials science, climate modelling, and beyond.
In conclusion, the conceptual framework demonstrated by the Gemini 2.0 AI Agents, with its emphasis on modular AI agents, diverse LLM utilization, and specialized tool use, represents a compelling new paradigm for scientific problem-solving. By intelligently decomposing complex challenges and orchestrating specialized AI components, this approach offers a powerful pathway to unravelling some of the most enduring mysteries in science, ushering in an era of accelerated discovery and innovation.
Tags: Agentic AI, AI, Open Source